1Ordonez NG.Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serouscarcinomas[].The American Journal of Surgical Pathology.1998
2DoglioniC,DeiJosAP,LaurinoL,etal.Calretinen:Anovalimmunohisto chemicalmarkerformesothelioma[].The American Journal of Surgical Pathology.1996
3Gotzos V,Wintergerst ES,Must JP,et al.Selective distribution if calretinen in adenocarcinoma of the Human colon and adjacent tissue[].The American Journal of Surgical Pathology.1999
4Wick MR.Editorial: Immunophenotying of malignant mesothelioma[].The American Journal of Surgical Pathology.1997
5Ordonez NG.The value of antibodies 44-3A6, SM3, HBME-1 and thromomodulin in differentiating epithelial pleural meso-Thelioma from lung adenocarcinoma.A comparative study with other commonly used antibodies[].The American Journal of Surgical Pathology.1997
2Ordonez NG. Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serouseareinomas.Am J Surg Pathol, 1998, 22(10): 1203 - 1214.
3Doglioni C, Tos AP, Laurinol, et al. CAL: a novel immunocytochemical marker for mesothelioma. Am J Surg Pathol, 1996,20(9) : 1037 - 1046.
4Ordonez NG. Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serouscarcinomas.Am J Surg Pathol, 1998, 22(10): 1203 - 1214
5Doglioni C, Tos AP, Laurinol, et al. CAL: a novel immunocytochemical marker for mesothelioma. Am J Surg Pathol, 1996,20(9): 1037 - 1046
6Doglioni C, Dei Tos A P, Laurino L, et al. Calretinin:a noval im- munocytochemical marker for mesothelioma [ J ]. Am J Surg Pathol, 1996,20(9) :1037 -46.
7Murugan P, Siddaraju N, Habeebullah S, et al. Immunohisto- chemical distinction between mesothelial and adenocarcinoma cells in serous effusions: a combination panel-based approach with a brief review of the literature[ J]. Indian J Pathol Microbiol, 2009,52(2) :175 -81.
8Betta P G, Magnani C, Bensi T, et al. Immunohistochemistry and molecular diagnostics of pleural malignant mesothelioma[ J ]. Arch Pathol Lab Med, 2012,136(3) :253 -61.
